ArticleApplied and environmental microbiology2026
Degradation pathway of (R)-1,3-butanediol in
Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
1,3-Butanediol (1,3-BDO) is widely used in consumer and industrial products; however, its microbial degradation remains poorly understood. Here, we dissect the catabolic and regulatory mechanisms of (R)-1,3-BDO utilization in IMPORTANCE: 1,3-Butanediol is an increasingly prevalent industrial chemical whose environmental fate depends on microbial degradation. Understanding how microorganisms sense and metabolize this compound is therefore essential for both environmental microbiology and biotechnology. This study clarifies the genetic and regulatory basis of (R)-1,3-BDO catabolism in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.